Recursion Pharmaceuticals, Inc. (RXRX)

CIK 1601830 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Recursion Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 202640001601830-26-000105
Sep 8, 20261440001628280-26-060859
Sep 2, 202640001601830-26-000103
Sep 1, 20261440001959173-26-006610
Aug 21, 20261440001959173-26-006306
Aug 20, 20261440001959173-26-006256
Aug 19, 20261440001959173-26-006204
Aug 18, 20261440001959173-26-006192
Aug 18, 202640002020969-26-000006
Aug 18, 202640001712276-26-000009
Aug 18, 202640002006495-26-000012
Aug 13, 20261440001959173-26-005979
Aug 12, 20261440001959173-26-005928
Aug 10, 20261440001959173-26-005848
Aug 7, 20261440001959173-26-005744
Aug 7, 2026SCHEDULE 13G0000093751-26-000530
Aug 6, 202640001856094-26-000014
Aug 5, 20268-K0001601830-26-000097
Aug 5, 202610-Q0001601830-26-000098
Aug 4, 20261440001959173-26-005577
Aug 4, 20261440001959173-26-005593
Jul 31, 2026SCHEDULE 13G0002100119-26-001441
Jul 31, 2026SCHEDULE 13G0002100121-26-000994
Jul 30, 20261440001959173-26-005467
Jul 29, 20261440001959173-26-005445